BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis plan

INTRODUCTION: Real-world data on COVID-19 vaccine effectiveness are needed to validate evidence from randomized clinical trials. Accordingly, this study aims to evaluate, in a real-world setting in Brazil, the effectiveness of Pfizer-BioNTech BNT162b2 against symptomatic COVID-19 and COVID-19-relate...

Descripción completa

Detalles Bibliográficos
Autores principales: Goulart Rosa, Regis, Spinardi, Julia, Allen, Kristen E., Manfio, Josélia, de Araujo, Cintia Laura Pereira, Cohen, Mírian, Robinson, Caroline Cabral, Sganzerla, Daniel, Ferreira, Diogo, de Souza, Emanuel Maltempi, de Oliveira, Jaqueline Carvalho, Gradia, Daniela Fiori, Brandalize, Ana Paula Carneiro, Kucharski, Gabriela Almeida, Pedrotti, Fernando, Rodrigues, Cristina de Oliveira, Kyaw, Moe H., Castillo, Graciela del Carmen Morales, Srivastava, Amit, McLaughlin, John M., Falavigna, Maicon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584383/
https://www.ncbi.nlm.nih.gov/pubmed/36264905
http://dx.doi.org/10.1371/journal.pone.0276384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584383/
https://www.ncbi.nlm.nih.gov/pubmed/36264905
http://dx.doi.org/10.1371/journal.pone.0276384

Ejemplares similares